TheEdgeResearch
Home / Stocks / MDCX

Medicus Pharma Ltd. Common Stock (MDCX)

NASDAQ Healthcare Biotechnology
$0.17 ▼ -0.18%
Market Cap
$3.8M
Sector
Healthcare
Industry
Biotechnology
Beta
-0.61
52-Wk Range
0.144-3.05
CEO
Raza Bokhari
Country
CA
Currency
USD

Medicus Pharma Ltd. Common Stock operates in the Biotechnology industry of the Healthcare sector, headquartered in West Conshohocken, PA, CA. The stock last traded at $0.17, down 0.18% on the session, giving a market capitalisation of $3.8M. On trailing twelve-month figures it carries a trailing P/E of -0.11, a net margin of 0.0%. Its beta of -0.61 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.11
Price / Sales
0.00
Price / Book
-7.54
EV / EBITDA
-0.21
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-12.27
Current ratio
1.57
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
16
IPO date
2024-11-15
Headquarters
West Conshohocken, PA, CA
About Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.

Comparable companies

Medicus Pharma Ltd. Common Stock is most often compared with the following Healthcare names:

ALGSBRNSCOEPCUECVMINMBIPSCKPTISKYETELO
More research on MDCX
MDCX technical analysis MDCX TheEdge Score Compare against peers
Open full interactive analysis & DCF →